Methylene Blue
A synthetic phenothiazine dye and the world's oldest synthetic drug (1876). Acts as an alternative electron carrier in the mitochondrial electron transport chain, bypassing Complex I and III dysfunction. At nanomolar doses, it enhances mitochondrial respiration, ATP production, and demonstrates remarkable neuroprotective effects in neurodegenerative disease models.
Reviewed & fact-checked by
Dr. Jane Smith, MD, PhDChief Medical Reviewer · Last updated: March 25, 2026
Medical Disclaimer: The information on this page is for educational and research purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
Why Methylene Blue Is Different From Every Other Nootropic
Methylene Blue (MB) is not a supplement in the conventional sense. It is the world's oldest synthetic drug, first synthesised in 1876 by Heinrich Caro and used as an antimalarial before penicillin existed. It has FDA approval as Provayblue for methemoglobinaemia. This pharmacological heritage means the mechanism of action and safety profile are extraordinarily well-characterised compared to most compounds in the biohacking space.
What makes it uniquely interesting for longevity and cognitive enhancement is its role as an alternative electron carrier in the mitochondrial electron transport chain.
Mechanism of Action
Mitochondrial electron cycling: In normal mitochondrial function, electrons flow through Complexes I, II, III, and IV to produce ATP. When these complexes are dysfunctional (due to ageing, oxidative damage, or hypoxia), electron flow stalls, ATP production drops, and reactive oxygen species accumulate.
Methylene Blue inserts itself directly into this chain. It accepts electrons from NADH (upstream of Complex I) and donates them to cytochrome c (downstream of Complex III), effectively short-circuiting the dysfunctional complexes and restoring electron flow. This is a genuinely unique mechanism not replicated by any other available compound.
Hormetic antioxidant: At low doses, MB is pro-oxidant (stimulating mitochondrial respiration). At high doses, it becomes antioxidant. This hormetic dose-response is characteristic of the most effective longevity compounds and explains why low-dose protocols are emphasised.
Neuroprotection: MB inhibits nitric oxide synthase and guanylate cyclase, reducing neuroinflammation. In Alzheimer's disease models, it disaggregates tau protein and reduces amyloid-beta accumulation.
The Non-Negotiable Safety Rule
Methylene Blue + SSRIs/SNRIs = Life-threatening serotonin syndrome.
This is not a theoretical concern. There are published case reports of fatal serotonin syndrome from this combination. MB inhibits MAO-A, making it functionally similar to an MAOI. Anyone taking antidepressants, anti-anxiety medications, or any serotonergic compound must not use Methylene Blue.
Grade Matters More Than Dosage
Only USP pharmaceutical grade Methylene Blue is appropriate for human use. Aquarium-grade and industrial-grade MB contain heavy metal contaminants including arsenic, lead, and zinc at concentrations that make them genuinely toxic. The price difference is significant - do not substitute.
Stacking Interactions
How Methylene Blue interacts with other compounds
The Advanced Mitochondrial stack. NMN daily; Methylene Blue on training or demanding cognitive days.
PQQ stimulates mitochondrial biogenesis (new mitochondria); Methylene Blue optimises electron transport in existing mitochondria. Complementary targets.
Both have dopaminergic activity. Combining is generally safe but monitor for overstimulation. Do not combine Methylene Blue with any serotonergic compounds.
Safety Profile — Tier B
Generally safe — moderate evidence
Contraindications
- ●G6PD deficiency - can cause severe haemolytic anaemia
- ●Serotonin syndrome risk - absolute contraindication with SSRIs, SNRIs, MAOIs
- ●Pregnancy - insufficient safety data at nootropic doses
- ●Glucose-6-phosphate dehydrogenase deficiency
Side Effects
- ●Blue/green urine and stool discolouration - harmless and expected
- ●Blue skin tint at higher doses - cosmetically undesirable
- ●Nausea at doses above 1mg/kg
- ●Serotonin syndrome if combined with serotonergic medications - serious risk
- ●Headache in some users